Cardiol Therapeutics Inc Class A (CRDL : TSX)
Common Stock
$1.32
CAD
-0.71 (-34.98%)
Last updated: 2026-10-05
Follow CRDL
CRDL
Cardiol Therapeutics Inc Class A
WealthAwesomePerformance
1 Day
-4.93%
1 Week
-19.25%
1 Month
-36.72%
YTD
+41.91%
Key Statistics
Market Cap
$234.52M
52W High
$3.23
52W Low
$1.23
P/E Ratio
-
50 Day MA
$2.43
200 Day MA
$1.78
Beta
0.72
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/5/2026 | $2.03 | $2.04 | $1.83 | $1.93 | $1.93 | 500,521 |
| 10/2/2026 | $2.28 | $2.33 | $2.00 | $2.03 | $2.03 | 599,499 |
| 10/1/2026 | $2.36 | $2.36 | $2.18 | $2.23 | $2.23 | 193,600 |
| 9/30/2026 | $2.42 | $2.42 | $2.33 | $2.37 | $2.37 | 76,319 |
| 9/29/2026 | $2.38 | $2.42 | $2.38 | $2.41 | $2.41 | 118,185 |
| 9/28/2026 | $2.40 | $2.41 | $2.35 | $2.39 | $2.39 | 113,102 |
| 9/25/2026 | $2.44 | $2.45 | $2.37 | $2.43 | $2.43 | 125,137 |
| 9/24/2026 | $2.41 | $2.46 | $2.35 | $2.43 | $2.43 | 241,292 |
| 9/23/2026 | $2.66 | $2.71 | $2.42 | $2.49 | $2.49 | 396,819 |
| 9/22/2026 | $2.64 | $2.76 | $2.61 | $2.67 | $2.67 | 237,992 |
Analyst Price Targets
Based on analyst covering CRDL · as of Sep 17, 2026
Wall Street analysts forecast CRDL stock price to rise 354.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+354.5% Upside
Current Price
C$1.32
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
76.8%
Annualized
90-Day Vol
66.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.31
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.05 | C$1.57 – C$2.67 |
| 60 trading days | C$2.17 | C$1.49 – C$3.16 |
| 90 trading days | C$2.31 | C$1.46 – C$3.65 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-35.85M
- Profit Margin
- 0.00%
- ROE (TTM)
- -190.18%
- EPS (Diluted)
- -0.36
- Book Value
- 0.21
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CRDL
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
CRDL.TO news timeline
15 articles covering CRDL.TO, most recent first
LatestWhy Cardiol Therapeutics Inc Class A stock is tanking today
October 2026
September 2026
- What's Going On With Cardiol Therapeutics Inc Class A Stock Wednesday?
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Friday?
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- Why Cardiol Therapeutics Inc Class A stock plummeted yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Monday?
- Why Cardiol Therapeutics Inc Class A stock surged yesterday
- What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?